Basit öğe kaydını göster

dc.contributor.authorDerin, Okan
dc.contributor.authorFonseca, Limirio
dc.contributor.authorSalas, Rafael
dc.contributor.authorRoberts, Matthew
dc.date.accessioned2020-12-01T07:02:06Z
dc.date.available2020-12-01T07:02:06Z
dc.date.issued2020en_US
dc.identifier.citationDerin, O., Fonseca, L., Salas, R. ve Roberts, M. (2020). Infectious complications of prostate biopsy: Winning battles but not war. World Journal of Urology, 38(11), 2743-2753. https://dx.doi.org/10.1007/s00345-020-03112-3en_US
dc.identifier.issn0724-4983
dc.identifier.issn1433-8726
dc.identifier.urihttps://dx.doi.org/10.1007/s00345-020-03112-3
dc.identifier.urihttps://hdl.handle.net/20.500.12511/6063
dc.description.abstractBackground Prostate biopsy is a standard tool for diagnosing prostate cancer, with more than 4 million procedures performed worldwide each year. Infectious complications and economic burden are reportedly rising with continued use of trans-rectal ultrasound-guided biopsy, despite the transperineal approach being associated with less infectious complications. Objective and methods In this review, the contemporary literature on pathophysiology, epidemiology, risk factors, causative organisms and emerging approaches for prevention of infectious complications are outlined. Results Management of infectious complications after TRUSB has caused significant financial burden on health systems. The most frequent causative agents of infectious complications after prostate biopsy are Gram-negative bacilli are particularly concerning in the era of antibiotic resistance. Increasing resistance to fluoroquinolones and beta-lactam antibiotics has complicated traditional preventive measures. Patient- and procedure-related risk factors, reported by individual studies, can contribute to infectious complications after prostate biopsy. Conclusions Recent literature shows that the transrectal ultrasound-guided prostate biopsy results in higher infectious complication rate than the transperineal prostate biopsy. NAATs, recently introduced technique to detect FQr may detect all antibiotic-resistant rectal microbiota members-included MDRs-although the technique still has limitations and economical burdens. Transient solutions are escalating antibiotic prophylaxis and widening the indications for TPB.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectProstate Biopsyen_US
dc.subjectInfectious Complicationsen_US
dc.subjectAntimicrobial Resistanceen_US
dc.subjectPreventive Measuresen_US
dc.titleInfectious complications of prostate biopsy: Winning battles but not waren_US
dc.typearticleen_US
dc.relation.ispartofWorld Journal of Urologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalıen_US
dc.authorid0000-0001-6311-5428en_US
dc.identifier.volume38en_US
dc.identifier.issue11en_US
dc.identifier.startpage2743en_US
dc.identifier.endpage2753en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1007/s00345-020-03112-3en_US
dc.identifier.wosqualityQ1en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster